申请人:Beth Israel Deaconess Medical Center, Inc.
公开号:US20140171440A1
公开(公告)日:2014-06-19
The present invention is directed to methods of enhancing liver repair after injury, resection or transplantation using antagonists of the bone morphogenetic protein (BMP) signaling pathway in the liver.